Can community-based interventions help to close the epilepsy treatment gap?

More than 50 million people have epilepsy; about 80% live in lower- or middle-income countries, where diagnosis and treatment can be difficult or impossible. The percentage of people with epilepsy that is not receiving treatment is known as the treatment gap; in some countries, this gap exceeds 90%.

Read more

Suspended studies and virtual lab meetings: How the COVID-19 pandemic is affecting epilepsy researchers

How was epilepsy research forced to morph during the first few months of the COVID-19 pandemic? Researchers from 11 countries shared their experiences and thoughts on the future of laboratory research, clinical trials, and in-person conferences.

Read more

Improving treatment for psychogenic seizures: “This is a group of patients that we are taking less seriously”

Journal prize winner Benjamin Tolchin tested motivational interviewing to help people with psychogenic non-epileptic seizures (PNES) start and continue psychotherapy. Often mistaken for epilepsy, these seizures cause serious problems, yet many health care professionals discount them as “not real.”

Read more

When seizures don’t stop: What’s the latest in treating status epilepticus?

When seizures last longer than about 5 minutes–a condition called status epilepticus–emergency treatment is required. About two-thirds of people respond to initial treatment with benzodiazepines, but the others need a second drug. Which drug to choose is a matter of some debate.

Read more

Two Steps Closer to Flexible, Powerful, Fast Bioelectronic Devices

Led by Biomedical Engineering Prof Dion Khodagholy, researchers have designed biocompatible ion-driven soft transistors that can perform real-time neurologically relevant computation and a mixed-conducting particulate composite that allows creation of electronic components out of a single material. These have promise for bioelectronic devices that are fast, sensitive, biocompatible, soft, and flexible, with long-term stability in physiological environments such as the human body. In particular, they could facilitate diagnosis and monitoring of neurological disease.

Read more